Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
BelgiumA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
BulgariaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
AustriaA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
BelgiumA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
BulgariaA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
FranceLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
BelgiumA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
AustriaA study of navenibart for long-term safety in patients with hereditary angioedema
AustriaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
